What's in the Cards for Healthpeak Properties This Earnings Season?

Healthpeak Properties, Inc. DOC is slated to report its fourth-quarter 2024 results on Feb. 3, after market close. While the quarterly results are expected to reflect year-over-year growth in revenues, funds from operations (FFO) per share might exhibit a decline.See the Zacks Earnings Calendar to stay ahead of market-making news.In the last reported quarter, this healthcare real estate investment trust (REIT) posted an FFO as adjusted per share of 45 cents, beating the Zacks Consensus Estimate by a penny. Results reflected better-than-anticipated revenues. Moreover, growth in total merger-combined same-store cash (adjusted) net operating income was witnessed across the portfolio.In the preceding four quarters, Healthpeak’s FFO, as adjusted per share, surpassed the Zacks Consensus Estimate on all occasions, with the average beat being 2.26%. The graph below depicts this surprise history: Healthpeak Properties, Inc. Price and EPS Surprise Healthpeak Properties, Inc. price-eps-surprise | Healthpeak Properties, Inc. Quote Factors at Play for HealthpeakThe increasing life expectancy of the U.S. population and biopharma drug development growth opportunities have promoted lab real estate market fundamentals. Healthpeak’s focus on the lab segment is a strategic fit and is expected to have been positively impacted by this tailwind, aiding revenue growth in the fourth quarter.Moreover, the senior citizen population is on the rise, and the healthcare expenditure of this age cohort is usually on the higher end compared with the general population. Healthpeak’s continuing care retirement community portfolio, which refers to its retirement communities that include independent living, assisted living and skilled nursing units, is anticipated to have benefited from this positive expenditure trend, supporting the segment’s quarterly performance.For the fourth quarter, the Zacks Consensus Estimate for DOC’s rental and related revenues currently stands at $544 million, implying growth of 31.9% from the prior-year period’s reported figure.The Zacks Consensus Estimate for fourth-quarter total revenues is pegged at $689.2 million, indicating a rise of 24.5% from the year-ago reported number.However, high interest expenses during the fourth quarter are likely to have been a spoilsport for Healthpeak.Before the fourth-quarter earnings release, the company’s activities were inadequate to gain analysts’ confidence. The Zacks Consensus Estimate for the quarterly FFO per share has remained unchanged at 45 cents over the past three months. The figure suggests a 2.17% decrease from the year-ago quarter’s tally.What Our Quantitative Model Predicts for HealthpeakOur proven model does not conclusively predict a surprise in terms of FFO per share for DOC this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an FFO beat, which is not the case here.Healthpeak currently has an Earnings ESP of -0.74% and carries a Zacks Rank of 3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.Stocks That Warrant a LookHere are two stocks from the broader REIT sector — Vornado Realty Trust VNO and Ventas VTR — that you may want to consider, as our model shows that these have the right combination of elements to report a surprise this quarter.Vornado Realty is slated to report quarterly numbers on Feb. 10. VNO has an Earnings ESP of +2.25% and a Zacks Rank of 3 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.Ventas is slated to report quarterly numbers on Feb. 12. VTR has an Earnings ESP of +0.89% and carries a Zacks Rank of 3 at present.Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ventas, Inc. (VTR): Free Stock Analysis Report Vornado Realty Trust (VNO): Free Stock Analysis Report Healthpeak Properties, Inc. (DOC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks